INTELLIGENT BIO SOLUTIONS INC. (INBS) Current Ratio
- Current ratio · latest quarter: Value 1.44×; Formula and calculation Current assets / current liabilities..
Current ratio
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Current ratio · latest quarter | 1.44× | Current assets / current liabilities. $7.10M ÷ $4.93M ≈ 1.44× |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Current assets | 7.10M USD | Assets, Current |
| Current obligations | 4.93M USD | Liabilities, Current |
| Cash and equivalents | 3.99M USD | Cash and Cash Equivalents, at Carrying Value |
| Short-term securities | (m) | |
| Customer receivables | 848.46K USD | Accounts Receivable, after Allowance for Credit Loss, Current |
| Inventory | 418.58K USD | Inventory, Net |
| Payables | 712.45K USD | Accounts Payable, Current |
| Borrowing debt due within one year | (m) |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Current assets (USD) | Current obligations (USD) | Cash and equivalents (USD) | Short-term securities (USD) | Customer receivables (USD) | Inventory (USD) | Payables (USD) | Borrowing debt due within one year (USD) | Current ratio |
|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $7.10M | $4.93M | $3.99M | (m) | $848.46K | $418.58K | $712.45K | (m) | 1.44× |
| 2026-03-31 | $9.75M | $4.61M | $6.86M | (m) | $878.36K | $597.47K | (m) | (m) | 2.11× |
| 2025-12-31 | $12.17M | $5.13M | $740.37K | (m) | $456.66K | $590.25K | (m) | (m) | 2.37× |
| 2025-09-30 | $4.48M | $5.06M | $1.66M | (m) | $717.82K | $628.18K | (m) | (m) | 0.89× |
| 2025-06-30 | $4.14M | $5.35M | $1.02M | (m) | $594.61K | $635.22K | $897.26K | (m) | 0.77× |
| 2025-03-31 | $5.11M | $4.56M | $2.81M | (m) | $510.96K | $683.49K | (m) | (m) | 1.12× |
| 2024-12-31 | $4.06M | $4.40M | $2.24M | (m) | $266.08K | $701.28K | (m) | (m) | 0.92× |
| 2024-09-30 | $6.48M | $5.68M | $3.99M | (m) | $578.58K | $738.79K | (m) | (m) | 1.14× |
| 2024-06-30 | $8.53M | $5.45M | $6.30M | (m) | $429.70K | $777.54K | (m) | (m) | 1.57× |
| 2024-03-31 | $11.52M | $5.71M | $9.40M | (m) | $431.65K | $877.90K | (m) | (m) | 2.02× |
| 2023-12-31 | $2.94M | $5.18M | $1.12M | (m) | $262.83K | $942.05K | (m) | (m) | 0.57× |
| 2023-09-30 | $2.69M | $6.85M | $186.40K | (m) | $567.51K | $965.09K | (m) | (m) | 0.39× |
| 2023-06-30 | $3.86M | $5.88M | $1.54M | (m) | $293.86K | $979.91K | (m) | (m) | 0.66× |
| 2023-03-31 | $4.42M | $3.54M | $2.28M | (m) | $296.05K | $736.22K | (m) | (m) | 1.25× |
| 2022-12-31 | $6.38M | $4.81M | $2.91M | (m) | $278.32K | $670.97K | (m) | (m) | 1.32× |
| 2022-09-30 | $8.21M | $2.36M | $5.74M | (m) | (m) | (m) | (m) | (m) | 3.48× |
| 2022-06-30 | $10.87M | $4.66M | $8.24M | (m) | (m) | (m) | (m) | (m) | 2.33× |
| 2022-03-31 | $12.87M | $4.43M | $10.76M | (m) | (m) | (m) | (m) | (m) | 2.90× |
| 2021-12-31 | $14.09M | $4.01M | $11.19M | (m) | (m) | (m) | (m) | (m) | 3.51× |
| 2021-09-30 | $15.86M | $2.83M | $12.61M | (m) | (m) | (m) | (m) | (m) | 5.60× |
| 2021-06-30 | $18.21M | $3.68M | $12.57M | (m) | (m) | (m) | (m) | (m) | 4.94× |
| 2021-03-31 | $16.59M | $1.56M | $14.26M | (m) | (m) | (m) | (m) | (m) | 10.64× |
| 2020-12-31 | $19.97M | $1.17M | $19.88M | (m) | (m) | (m) | (m) | (m) | 17.12× |
| 2020-06-30 | $2.34M | $7.69M | $427.27K | (m) | (m) | (m) | (m) | (m) | 0.30× |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sonoma Pharmaceuticals, Inc. (SNOA) | United States | $0.006B | -2.59 |
| AETHLON MEDICAL INC (AEMD) | United States | $0.005B | |
| enVVeno Medical Corp (NVNO) | United States | $0.006B | -0.48 |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Co-Diagnostics, Inc. (CODX) | United States | $0.007B | -0.32 |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |